Skip to main content
Clinical Trials/JPRN-UMIN000004028
JPRN-UMIN000004028
Completed
未知

Multicenter prospective Study to determine the efficacy of Strontium-89 for palliation of painful bone metastases in cancer patients - PMS-89

PMS-89 Study Group0 sites200 target enrollmentAugust 10, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
painful bone metastases
Sponsor
PMS-89 Study Group
Enrollment
200
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 10, 2010
End Date
October 5, 2015
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
PMS-89 Study Group

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\)severe myelosupppression 2\)marked fall of hematological function 3\)Administration of Sr\-89 within previous 3 months 4\)DIC 5\)Severe renal disfunction 6\)Multiple myeloma 7\)Pregnancy 8\)Any condition, which, in the opinion of the investigator, might interfere with the evaluation of the study objectives

Outcomes

Primary Outcomes

Not specified

Similar Trials